STAAR Surgical Company (NASDAQ:STAA) Receives $20.67 Average Target Price from Brokerages

STAAR Surgical Company (NASDAQ:STAA) has been assigned a consensus rating of “Reduce” from the eleven brokerages that are presently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell rating and ten have assigned a hold rating to the company. The average 1-year price objective among analysts that have issued a report on the stock in the last year is $20.6667.

STAA has been the subject of several research analyst reports. Stifel Nicolaus set a $28.00 price objective on STAAR Surgical and gave the company a “hold” rating in a report on Thursday, August 7th. Mizuho boosted their target price on STAAR Surgical from $17.00 to $18.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 16th. Piper Sandler raised STAAR Surgical to a “hold” rating in a research report on Wednesday, June 18th. Canaccord Genuity Group boosted their target price on STAAR Surgical from $20.00 to $28.00 and gave the stock a “hold” rating in a research report on Wednesday, August 6th. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of STAAR Surgical in a research report on Wednesday.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the business. Linden Thomas Advisory Services LLC increased its position in STAAR Surgical by 3.0% in the 1st quarter. Linden Thomas Advisory Services LLC now owns 20,978 shares of the medical instruments supplier’s stock worth $370,000 after purchasing an additional 603 shares during the last quarter. CWM LLC increased its position in STAAR Surgical by 74.1% in the 2nd quarter. CWM LLC now owns 1,563 shares of the medical instruments supplier’s stock worth $26,000 after purchasing an additional 665 shares during the last quarter. GAMMA Investing LLC increased its position in STAAR Surgical by 61.4% in the 3rd quarter. GAMMA Investing LLC now owns 1,856 shares of the medical instruments supplier’s stock worth $50,000 after purchasing an additional 706 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its position in STAAR Surgical by 7.8% in the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 12,711 shares of the medical instruments supplier’s stock worth $213,000 after purchasing an additional 923 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC increased its position in STAAR Surgical by 4.4% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 22,168 shares of the medical instruments supplier’s stock worth $396,000 after purchasing an additional 934 shares during the last quarter. 96.70% of the stock is owned by institutional investors and hedge funds.

STAAR Surgical Stock Up 1.9%

Shares of STAAR Surgical stock opened at $26.68 on Wednesday. The firm has a market cap of $1.32 billion, a price-to-earnings ratio of -13.82 and a beta of 0.82. The business has a fifty day simple moving average of $27.17 and a 200-day simple moving average of $20.92. STAAR Surgical has a fifty-two week low of $13.50 and a fifty-two week high of $33.28.

About STAAR Surgical

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.